Gauge Capital has announced it has invested in East Coast Institute for Research (ECIR).

ECIR, founded in 2007 and based in Jacksonville, Fla., is a clinical research site management organization focused primarily on the cardiovascular and metabolic therapeutic areas. The company has sites across northern Florida and Georgia.

Gauge, based in Southlake, Texas,

New State Capital Partners has announced it has acquired Agility Recovery Services.

Agility, based in Atlanta, is a provider of business continuity and disaster recovery services for healthcare organizations and customers in other sectors. Founded in 1989, Agility’s subscription-based services include access to backup power, temporary office space, network connectivity, and backup technology and equipment.

As the fee-for-service model in U.S. healthcare grows increasingly unpopular, shifting to a value-based care paradigm can move the healthcare system toward better outcomes, lower costs, better patient access and experiences — and greater investment opportunities.

In this episode of The Corner Series, McGuireWoods’ Geoff Cockrell is joined by Andrew Clark, managing partner

Gemspring Capital has announced it has sold Valant Medical Solutions to an affiliate of Resurgens Technology Partners.

Valant, founded in 2005 and based in Seattle, is provider of SaaS-based electronic health record and practice management software for behavioral health providers.

Gemspring, based in Westport, Conn., is a middle market private equity firm that

On Nov. 30, the Illinois Supreme Court, in Mosby v. The Ingalls Memorial Hospital et al., held that certain healthcare providers’ biometric data, used for healthcare operational purposes under the Health Insurance Portability and Accountability Act, is not protected under the Illinois Biometric Information Privacy Act. Read on for details about this development and

On Dec. 6, the U.S. Food and Drug Administration sent a warning letter to the owners of online hemp, tetrahydrocannabinol and cannabidiol retailer Hemp-xr.com for introducing adulterated foods into interstate commerce. FDA took issue with certain cookies, edibles, gummies and honey containing delta-8 THC and CBD because they “bear or contain an unsafe food additive.”